Cardiovascular

Latest News

Blood pressure monitor on patient's arm | Image credit: CasanoWa Stutio – stock.adobe.com
Delayed Hypertension Diagnosis Tied to Higher Cardiovascular Risk, Lower Treatment Rates

July 14th 2025

Researchers found a 30% increased risk of cardiovascular events in patients whose diagnosis was delayed by more than a year after an elevated blood pressure reading.

Cardiologist listening to patient's heart | Image credit: Space_Cat – stock.adobe.com
40% of Patients With Heart Failure Don’t See Cardiologist Annually, Increasing Risk of Death

June 19th 2025

Gaps in the Coordination of Care for Older Adults With or at Risk for Cardiovascular Disease
Gaps in the Coordination of Care for Older Adults With or at Risk for Cardiovascular Disease

June 3rd 2025

CBD oils and hemp leaves | Image credit: Irina_Evva – stock.adobe.com
CBD-Based Drug Shows No Heart Safety Risks in Patients With CVD or Risk Factors

May 23rd 2025

AJMC
Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

May 16th 2025

Lipoprotein(a) and Cardiovascular Risk

Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.

AJMC Peer Exchange logo
Continuing Medical Education
View All
July 16th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 16th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology
July 16th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
July 16th 2025

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology
July 16th 2025

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases
July 16th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

Cholesterol Management and Long-Term Cardiovascular Disease Prevention
April 13th 2017

Cholesterol Management and Long-Term Cardiovascular Disease Prevention

PCSK9 Inhibitors: Cost Concerns and Access
April 13th 2017

PCSK9 Inhibitors: Cost Concerns and Access

Clinical Experience With PCSK9 Inhibitors
April 13th 2017

Clinical Experience With PCSK9 Inhibitors

Alternate Mechanisms of Action for Cholesterol Management
April 13th 2017

Alternate Mechanisms of Action for Cholesterol Management

Candidacy for Later-Line Cholesterol-Lowering Therapies
April 13th 2017

Candidacy for Later-Line Cholesterol-Lowering Therapies

Management of High-Risk Populations With Hyperlipidemia
April 13th 2017

Management of High-Risk Populations With Hyperlipidemia

Efficacy and Safety of PCSK9 Inhibitors
April 13th 2017

Efficacy and Safety of PCSK9 Inhibitors

Lipid Management: Coverage Criteria vs FDA Labeling
April 13th 2017

Lipid Management: Coverage Criteria vs FDA Labeling

Coverage of Statins/Nonstatins in Lipid Management
April 13th 2017

Coverage of Statins/Nonstatins in Lipid Management

Cholesterol Goals in Primary Cardiovascular Disease Prevention
April 13th 2017

Cholesterol Goals in Primary Cardiovascular Disease Prevention

Early Detection of Risk and Familial Hypercholesterolemia
April 13th 2017

Early Detection of Risk and Familial Hypercholesterolemia

Managed Care Decision Making in CVD and Lipid Control
April 13th 2017

Managed Care Decision Making in CVD and Lipid Control

Current CVD Prevention and Management Challenges
April 13th 2017

Current CVD Prevention and Management Challenges

Dr Janet Wright Discusses How Million Hearts Will Leverage Partnerships for Success
April 6th 2017

Dr Janet Wright Discusses How Million Hearts Will Leverage Partnerships for Success

The Million Hearts initiative, which aims to prevent a million cardiovascular events in a 5-year period, will focus on utilizing its partnerships with health systems and employers as it embarks upon its second phase, according to Janet Wright, MD, FACC, the program’s executive director.
Site Logo
March 30th 2017

Cardiovascular Outcome Trials: How Misinterpretation of Statistics Can Affect Clinical Practice

Michael R. Page, PharmD, RPh
At the Academy of Managed Care Pharmacy Annual Meeting in Denver, Colorado, Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN, of Midwest Biomedical Research/Center for Metabolic and Cardiovascular Health in Chicago, Illinois, discussed methods of quantifying treatment effects in cardiovascular outcomes trials.
Site Logo
March 30th 2017

Dr Clifford Goodman Outlines Takeaways From a Health Economic Case Study on Repatha

During an industry workshop at the Academy of Managed Care Pharmacy Annual Meeting in Denver, Colorado, Cliff Goodman, PhD, of the Lewin Group, moderated a session that provided a health economic case study on cardiovascular outcome data for Repatha (evolocumab), the PCSK9 inhibitor from Amgen.
Dr Alex C. Spyropoulos Discusses the Patient-Centered Directions of Rivaroxaban Research
March 28th 2017

Dr Alex C. Spyropoulos Discusses the Patient-Centered Directions of Rivaroxaban Research

According to Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC, professor of medicine at the Hofstra Northwell School of Medicine, research on rivaroxaban to prevent thrombosis is moving from determining efficacy to evaluating patient-centered outcomes in a variety of clinical situations, as evidenced by new studies like EINSTEIN-CHOICE and the MARINER trial.
Dr Jim McDermott Discusses Objectives and Outcomes of CVD-REAL Trial
March 20th 2017

Dr Jim McDermott Discusses Objectives and Outcomes of CVD-REAL Trial

The CVD-REAL study presented at the American College of Cardiology 66th Scientific Session asked whether cardiovascular outcomes seen in the EMPA-REG OUTCOME trial could be seen in a real-world environment, and for the entire class of SGLT2 inhibitors, according to AstraZeneca’s Jim McDermott, PhD, vice president for Medical Affairs, Diabetes.
Dr Janet Wright Outlines Goals and Roadblocks of Million Hearts Initiative
March 20th 2017

Dr Janet Wright Outlines Goals and Roadblocks of Million Hearts Initiative

The Million Hearts initiative launched in 2012 set a lofty goal of preventing 1 million cardiovascular deaths in 5 years, but did not quite achieve that target. According to the program’s executive director, Janet Wright, MD, FACC, Million Hearts will continue to make progress in part due to the solid foundations it has formed in the initial stage.
Site Logo
March 17th 2017

Women Taking Statins Faced Increased Diabetes Risk

AJMC Staff
The study found a "dose effect" in the elderly women who took statins to treat cholesterol.
Site Logo
March 16th 2017

Seniors Are Living Longer, Thanks to Medicare Part D

Mary Caffrey
The drop in mortality was driven by a significant drop in cardiovascular mortality, the leading cause of death among seniors.
Site Logo
March 11th 2017

Unmet Needs in Cardiovascular Risk Reduction

Site Logo
March 9th 2017

Marijuana Use Linked to High Risk of Heart Failure, Stroke

Christina Mattina
Researchers have identified another high associated with marijuana use: the risk of heart failure and cerebrovascular accidents.
Site Logo
February 15th 2017

In Light of SPRINT, How to Treat Hypertension?

Mary Caffrey
An author in JAMA points out some caveats to a ground-breaking trial.
Site Logo
February 4th 2017

FOURIER Study Finds Repatha Reduces Risk of Cardiovascular Events

Laura Joszt, MA
Amgen's Repatha was shown to reduce the risk of cardiovascular events, such as cardiovascular death and myocardial infarction, in phase 3 of the FOURIER study. Full results will be presented in March 2017 at the American College of Cardiology 66th Scientific Sessions.
Site Logo
January 31st 2017

AHA Calls for Timing Meals to Lower Cardiovascular Risk

Mary Caffrey
Busy lifestyles are eroding the lines of traditional meal times, and all-day eating is bad for cardiovascular health, the statement says.
Site Logo
January 17th 2017

What's as Bad for the Heart as Obesity? Try Depression

Mary Caffrey
The study found only tobacco use and hypertension were worse on the heart than depression.
Site Logo
January 16th 2017

Safety of Januvia in Oldest Patients With Diabetes Confirmed in Study

Mary Caffrey
The new study in Diabetes Care comes more than a year after the initial results of the TECOS trial were presented at the American Diabetes Association Scientific Sessions.
Site Logo
December 2nd 2016

Jardiance Gets CV Indication for Adults With Type 2 Diabetes

Mary Caffrey
Researchers considered finding a diabetes drug that also produced a cardiovascular benefit to be a "holy grail."
Site Logo
November 21st 2016

Intarcia Submits New Drug Application to FDA for Diabetes Treatment

Mary Caffrey
The matchstick-size pump has been heralded as a game changer in addressing the biggest problem in diabetes care: medication adherence.
<1
...
141516171819202122
...
24>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo